TrialJAMA2020

Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.

Kausik K Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.